ICU Medical, Inc. (ICUI) Stock
ICUI Key Statistics
About ICU Medical, Inc.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
CEO: Vivek Jain. Company website
ICUI — Frequently Asked Questions
What is the ICUI stock price today?
ICU Medical, Inc. (ICUI) trades at $152.65, down 0.17% on the day, as of Sep 20, 2026 14:58 UTC.
What is ICU Medical, Inc.'s market cap?
ICU Medical, Inc. has a market capitalisation of $3.82B, calculated from the live ICUI share price and shares outstanding.
What is the P/E ratio of ICUI?
ICUI trades at a trailing P/E of 129.36, from earnings per share of $1.18 over the last twelve months.
How much revenue does ICU Medical, Inc. make?
ICU Medical, Inc. generated revenue of $2.16B over the trailing twelve months, which puts the stock at 1.77 times sales.
What is the 52-week range for ICUI?
ICUI has traded between $112.50 and $192.85 over the past 52 weeks, and the last price is 20.8% below that high.
Is ICU Medical, Inc. profitable?
Yes. ICU Medical, Inc. keeps 1.39% of revenue as net income over the trailing twelve months.
What is the analyst price target for ICUI?
Wall Street analysts rate ICUI Buy, with an average price target of $186.40, 22.1% above the current price.
What sector is ICU Medical, Inc. in?
ICU Medical, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of ICU Medical, Inc.?
Vivek Jain is the chief executive of ICU Medical, Inc., which employs 13,000 people.
Where can I track ICUI in real time?
QFI Terminal shows ICUI with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See ICUI live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open ICUI in Terminal See plans